Cancer clinical trials: how they work and whether to join

A clinical trial is a carefully planned research study that tests whether a new treatment, a new combination or a new way of giving an existing treatment is safe and works better than, or as well as, the current standard. Every cancer medicine in use today was once studied in trials. Taking part is always voluntary, and you can leave a trial at any time without losing access to normal care. Joining does not mean you will personally benefit: the new treatment may turn out to be better, the same or worse than standard care, which is exactly why the study is being done. Whether to join is a personal decision to make with your oncologist and family.

Many cancer trials compare a new approach with the current standard treatment. In a randomised trial, a computer decides by chance which group each person joins, so that the comparison is fair; neither you nor your doctor chooses. A placebo is a dummy treatment with no active medicine. In cancer trials, a placebo is rarely given instead of treatment when an effective treatment exists. More often, everyone receives standard treatment, and some also receive the new medicine while others receive a placebo added to it. Some trials are blinded, meaning you, and sometimes your doctor, do not know which group you are in. The consent form should explain all of this clearly.

Trials are run in phases. Early phases test safety and suitable amounts in small groups, later phases compare the new treatment with standard care in larger groups, and the final phase follows a treatment after approval. In India, trials must be approved by the national drug regulator and an ethics committee, and registered on the Clinical Trials Registry of India, called CTRI, which anyone can search online. Trial medicines are often provided free, but travel, some tests and routine care may not be, so ask before agreeing. Each trial has strict entry rules, and your oncologist is the best person to discuss whether any trial is worth considering in your situation.

Taking part is voluntary

You can leave at any time and still receive care.

Benefit is not assured

Trials exist because the answer is not yet known.

Oversight protects participants

Ethics approval and CTRI registration are required in India.

It cannot tell you whether a trial is right for you or whether you would qualify. That needs a discussion with your oncologist and the trial team.

It also does not recommend or recruit for any trial. It explains how trials work so you can ask informed questions.

Should you join?

Some people join trials hoping for access to a new treatment, some to help future patients, and some decide the extra visits and uncertainty are not right for them. All of these are reasonable choices. Talk it through with your oncologist and family, and take the time you need rather than feeling rushed.

Will you get a placebo?

In most cancer trials, nobody is left without treatment when an effective one exists. If a placebo is used, it is usually added to standard treatment, so everyone still receives care. The consent form must say whether a placebo is used and what your chance is of receiving it.

What informed consent means

Before joining, you should receive written information in a language you understand, time to read it, and a chance to ask questions. Consent means understanding the purpose, the possible risks and benefits, the extra tests and your right to withdraw. Signing the form does not oblige you to stay in the trial.

Is trial treatment free?

The trial medicine is usually provided free by the sponsor, and some study-specific tests may be covered. Standard care, travel, accommodation and treatment for unrelated problems may not be. Ask for costs in writing, and ask what happens if a trial-related injury occurs, because Indian rules require compensation in such cases.

Who qualifies

Each trial has rules about cancer type, earlier treatment, test results, fitness, other health conditions, pregnancy and more. These rules protect participants and keep the results reliable. Not qualifying for a trial says nothing about the quality of your care; it simply means that study is not the right match.

Finding a trial in India

The Clinical Trials Registry of India lists trials approved in the country and can be searched online by condition and location. International registers also list some Indian sites. Your oncologist can help interpret the listings, check whether a trial is still open, and contact the trial team if it seems relevant.

The extra commitment

Trials often involve more visits, more blood tests and scans, questionnaires and a symptom diary. Some require staying near the trial centre for a period. Consider travel, time off work and family support before agreeing, and ask the trial team for a clear schedule of what taking part involves.

Safety and ethics

Trials in India must be approved by the national drug regulator and an ethics committee, which reviews the design, consent process and compensation arrangements. Serious side effects must be reported. Oversight reduces risk but cannot remove it, because a new treatment may have effects that are not yet known.

Leaving a trial

You can withdraw from a trial at any time, for any reason, without affecting your right to standard treatment. The trial team may ask for a final check for your safety. If you are thinking of leaving, talk to them and your oncologist so the move back to standard care is smooth.

Compassionate use

When no suitable trial exists and standard options have been used, some unapproved medicines may be available through compassionate use or expanded access programmes, which need regulatory permission. These routes are uncommon, and the benefit of the medicine is not yet established. Your oncologist can explain whether such a route is realistic.

Trials after cancer grows

Some trials are designed for people whose cancer has grown despite earlier treatment. Joining is one option among several, alongside other standard treatments and comfort-focused care. The decision depends on your fitness, your priorities and the trial's rules, and your oncologist can talk it through with you honestly.

Questions to ask before joining

Useful questions include what the trial is testing, what the alternatives are, whether a placebo is used, what extra visits and tests are needed, what it costs, who to call about side effects, what happens when the trial ends, and whether you could continue the treatment afterwards.

What to do next

Ask your oncologist whether any trial is relevant to your cancer, read the consent information carefully, write down your questions, discuss the decision with family, and remember that saying no is always acceptable.